Evidence map›Paper›PMID 31010950›Full record

ArticleDiabetes care2019

Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640.

Surya N Mulukutla, Maria Acevedo-Calado, Christiane S Hampe, Massimo Pietropaolo, Ashok Balasubramanyam

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Surya N MulukutlaDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX.
Maria Acevedo-CaladoDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX.
Christiane S HampeDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA.
Massimo PietropaoloDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX massimo.pietropaolo@bcm.edu ashokb@bcm.edu.
Ashok BalasubramanyamDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX massimo.pietropaolo@bcm.edu ashokb@bcm.edu.ORCID 0000-0003-2093-5201

Funding

IMPROVING PREDICTION OF IDDMR01DK053456 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HERMAN, MARK A, REDONDO, MARIA JOSE · 1999 to 2021
$9.5M
Arginine and Nitric Oxide Synthesis in the Pathogenesis of Ketosis-Prone DiabetesR01DK101411 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI BALASUBRAMANYAM, ASHOK, JAHOOR, FAROOK · 2014 to 2018
$2.1M
NIDDK NIH HHS R01 DK053456NIDDK NIH HHS R01 DK101411
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2KetosisAutoantibodiesHumansAutoantibodies

Identifiers

PMID31010950
PMCPMC6489110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.